To verify further the activation of Notch signalling in HCC cells by Tspan5, we treated HCC cells with the γ‐secretase inhibitor, dibenzazepine (DBZ, YO‐01027) for 24 h and then performed western blotting assays. This evidence concerns the gene TSPAN5 and hepatocellular carcinoma.